search
Back to results

Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants (TRIUMF)

Primary Purpose

Growth Disorders, Infant Malnutrition, Micronutrient Deficiency

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Macro-micronutrient complementary food supplement
A micronutrient powder
Nutrition education
Sponsored by
Nevin Scrimshaw International Nutrition Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Growth Disorders focused on measuring Complementary food supplement, Protein quality and linear growth, Intervention targeting complementary foods and growth

Eligibility Criteria

6 Months - 6 Months (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Non pre-term
  2. Singleton birth
  3. Exclusively or predominantly breast fed up to time of recruitment
  4. Parents planning to live in community for a period of 12 months and willing to participate in the trial for the entire period
  5. Receive informed consent from both parents and/or caregivers or from mother alone if single

Exclusion Criteria:

  1. Severely anemic (<7 g/dl) (to be referred to Community Health Post (CHP) for routine care on anemia as recommended by Ghana Health Service)
  2. Severely malnourished (MUAC <110 mm) (to be referred to CHP with Community-based Management of Acute Malnutrition (CMAM) protocol) and/or use of CMAM protocol or below -2 standard deviations (SD) weight for age Z score

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm Type

    Active Comparator

    Active Comparator

    Active Comparator

    No Intervention

    Arm Label

    KokoPlus and Nutrition Education

    Micronutrient and Nutrition Education

    Nutrition Education Only

    Growth Monitoring Only

    Arm Description

    Macro-micronutrient complementary food supplement and Nutrition Education

    A micronutrient powder and Nutrition Education

    Nutrition Education

    Growth monitoring

    Outcomes

    Primary Outcome Measures

    Change in monthly length for age Z-score (monthly LAZ)
    Change in length for age Z-score from 6 months to 18 months of age.

    Secondary Outcome Measures

    Change in Serum Hemoglobin
    Change in serum hemoglobin from baseline to endline (6 months to 18 months)
    Change in Serum retinol binding protein
    Change in serum retinol binding protein from baseline to endline (6 months to 18 months)
    Change in serum transferrin receptors
    Change from baseline to endline (6 months to 18 months)
    Change in serum ferritin
    Change from baseline to endline (6 months to 18 months)
    Change in serum zinc
    Change from baseline to endline (6 months to 18 months)
    Change in Weight for age Z-score
    This is the change in weight for age Z-score from 6 months to 18 months of age
    Change in Weight for height Z-score
    This is the change in weight for length Z-score from 6 months to 18 months of age
    Prevalence of diarrhea
    Prevalence of diarrhea over a 12 month period (duration of intervention)
    Prevalence of upper respiratory infections
    Prevalence of respiratory infections over a 12 month period (duration of the intervention)
    Change in serum C-reactive protein
    Change from baseline to endline (6 months to 18 months)
    Change in serum alpha glycoprotein
    Change from baseline to endline (6 months to 18 months)
    Change in Head Circumference for age
    This is the change in head circumference for age from 6 months to 18 months of
    Change in MUAC (Mid Upper Arm Circumference)
    This is the change in MUAC for age from 6 months to 18 months of age
    Change in Plasma Amino Acid levels
    This is the change in individual plasma amino acids from 6 months to 18 months

    Full Information

    First Posted
    June 5, 2017
    Last Updated
    February 27, 2018
    Sponsor
    Nevin Scrimshaw International Nutrition Foundation
    Collaborators
    University of Ghana, University of Cape Coast, Ajinomoto USA, INC., Ghana Health Services
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03181178
    Brief Title
    Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants
    Acronym
    TRIUMF
    Official Title
    Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants (6 to 18 Months)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    February 2013 (Actual)
    Primary Completion Date
    February 2015 (Actual)
    Study Completion Date
    February 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Nevin Scrimshaw International Nutrition Foundation
    Collaborators
    University of Ghana, University of Cape Coast, Ajinomoto USA, INC., Ghana Health Services

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Prevention of malnutrition in infants and children requires access and intake of nutritious food starting at birth with exclusive breastfeeding for the first 6 months of life, breastfeeding in combination with complementary foods from 6-24 months of age, access to clean drinking water and sanitation, access to preventive and curative health care (including prenatal). In Ghana, the Demographic and Health Survey of 2014 reports rates of stunting, wasting and underweight in children aged 0-59 months are 28%, 14% and 9% respectively. Furthermore, height for age starts dropping from age 4-6 months with children aged 6-23 months being more likely to be stunted (40%) than those below 6 months (4%). Infant and young child feeding data show that for breast-fed children ranging from 6 months through 35 months of age, cereals are predominantly the first foods introduced in the diet (6-8 months of age). As the child grows older, consumption of fruits rich in Vitamin A, other fruits and vegetables and meat, fish, poultry and eggs are reported by the mothers. The Demographic and Health Survey (DHS) found that the proportion of breast fed children aged 6-23 months who received a recommended variety of foods the minimum number of times per day increases with child's age from 28% in children 6-8 months to 50% in children aged 18-23 months. The study objective is to examine the effect of providing a macro- and micro-nutrient fortified complementary food supplement (KokoPlusTM) on growth and nutritional status of Ghanaian infants.
    Detailed Description
    The current study is a cluster randomized single blind intervention design study with three study arms that aimed to examine the effect of providing a macro- and micro-nutrient fortified complementary food supplement (KokoPlus) for a period of 12 months (starting at 6 months of age) on growth and nutritional status of Ghanaian infants at 18 months of age. KokoPlus was formulated using linear programming methodology based on formative and market analysis research findings. The subjects in this cluster-randomized trial are from communities in three districts of the Central region in Ghana with high rates of moderate and severe acute malnutrition. A total of 38 communities will be randomly assigned to one of three groups using block randomization and another 11 (randomly selected) will be followed cross sectionally as part of a fourth/non intervention group (growth monitoring). The total sample size is 1204. Sample size calculations were based on two outcome measures: expected reduction in diarrheal morbidity and growth (improvements in height-for-age). Sample size estimates for detecting a 0.5 cm change in height in children provided a caloric and non caloric micronutrient supplement using a design effect of 2, power of 0.80, alpha of 0.05 and assuming an attrition rate of 15%, the required sample size per group was 301. Mother-infant pairs will be recruited between infant age of 0 to 3 months to participate in monthly nutrition educations sessions and to encourage the women to continue exclusive breast feeding across all three groups. At 6 months of age, infants in each of the three groups were enrolled into the intervention study (upon receipt of informed consent). Data collection involves baseline, midline and endline measurements in the infants at 6, 12 and 18 months of age. In addition, participating mother-infant pairs will be visited weekly for delivery of the supplements and for morbidity monitoring and monthly for the measurement of anthropometry. Anthropometric measurements include: length (Infant/Child Shorr Height Board; Weigh and Measure, LLC ), weight (Seca 874 digital scale ), mid-upper arm circumference (MUAC) (Child MUAC Tape; Weigh and Measure, LLC), subscapular and triceps skinfolds (Holtain skinfold caliper ),head and chest circumference. Data collection at baseline, midline and endline included one venous sample (3ml) from the infant, HemoCue (Model 301) measurement to assess severe anemia (7 <g/dl) with appropriate referrals as mentioned earlier. Ethylenediaminetetracetic acid (EDTA) Vacutainers (BD ; catalog number 368841) for whole blood and plasma analyses and Trace Element Serum Separator Tube Vacutainers (BD; catalog number 368380) for serum analyses will be used for the sample collection with butterfly needles (21 or 23 gauge). Samples will be immediately placed in a super cooler tube rack and transported back to the lab within five hours where they were processed immediately. Questionnaires will be administered to assess socio-economic status, infant and young child feeding practices, morbidity (past week), household food security along with a 24 hour diet recall. Data was uploaded daily through cellular network, stored on Formhub and then Ona organization servers. The primary outcome of the study is the change in length for age Z-score from 6 to 18 months of age in infants in the KokoPlus group versus Micronutrient powder group and the Nutrition Education group. Data calculations included estimating anthropometric indices using the WHO (World Health Organization) 2006 growth reference charts using the WHO macro in STATA (18), computing the USAID Food and Nutrition Technical Assistance (FANTA) household insecurity access scores (HFIAS) (19) maternal body mass index (BMI), dietary diversity scores (20), and re-coding variables as required to binary and accounting for missing. Infant anthropometric indices calculated include length for age (LAZ) Z- score, weight for age Z-score (WAZ) and weight for length (WLZ score). All analyses are intent to treat. Descriptive statistics (means, medians, standard deviations and standard errors) were computed. To verify the randomization assumption, any differences in mean values at baseline across three groups were tested using linear mixed effects regression analyses accounting for clustering. The effect of the supplement (KokoPlus, Micronutrients and Nutrition Education group) on different dependent variables across the intervention period will be tested using mixed effects regression analyses accounting for clustering and repeated measures. The dependent variables tested included change in LAZ between baseline and endline (primary outcome), change in LAZ on a monthly basis (primary outcome 2), change in WAZ, WLZ, serum hemoglobin (unadjusted and adjusted for inflammation), serum ferritin (unadjusted and adjusted for inflammation), serum zinc, serum cortisol, serum insulin growth factor-1 (IGF-1), serum retinol binding protein, C-reactive protein and alpha glycoprotein, prevalence of acute and chronic infection. A cross-sectional assessment (anthropometry) will be conducted at baseline, midline and endline in 301 infants that are randomly selected from another set of communities (to be identified based on the same community selection criteria). These infants will not be followed longitudinally and the only measurements to be collected include weights and heights. Informed consent procedures will be similar to the three intervention arms. This group is a reference group only and cannot be included in any comparative analysis. Monitoring of groups that receive a supplement will happen weekly. Compliance will be defined based on the number of supplement packets that are consumed per week. To assure that the mothers are compliant in using the supplement, they will be asked to return the empty supplement packages at the end of the week. Optimal compliance will be defined as consumption of at least 50% of the weekly samples. Supplements will be provided in plastic or paper bags with a clearly labelled household ID (identity number). Compliance and dose response to compliance will be reviewed in existing studies to determine minimum compliance required.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Growth Disorders, Infant Malnutrition, Micronutrient Deficiency, Protein Malnutrition, Morbidity;Infant
    Keywords
    Complementary food supplement, Protein quality and linear growth, Intervention targeting complementary foods and growth

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    The study has three intervention arms and one cross sectional growth monitoring follow up group.
    Masking
    Participant
    Masking Description
    Single blind cluster randomized trial - all participants in a community received the same treatment.
    Allocation
    Randomized
    Enrollment
    1204 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    KokoPlus and Nutrition Education
    Arm Type
    Active Comparator
    Arm Description
    Macro-micronutrient complementary food supplement and Nutrition Education
    Arm Title
    Micronutrient and Nutrition Education
    Arm Type
    Active Comparator
    Arm Description
    A micronutrient powder and Nutrition Education
    Arm Title
    Nutrition Education Only
    Arm Type
    Active Comparator
    Arm Description
    Nutrition Education
    Arm Title
    Growth Monitoring Only
    Arm Type
    No Intervention
    Arm Description
    Growth monitoring
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Macro-micronutrient complementary food supplement
    Intervention Description
    This intervention provided a 15 g complementary food supplement called KokoPlus with nutrition education
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    A micronutrient powder
    Intervention Description
    This intervention provided a 1 g micronutrient powder with nutrition education
    Intervention Type
    Behavioral
    Intervention Name(s)
    Nutrition education
    Intervention Description
    This intervention provided nutrition education sessions
    Primary Outcome Measure Information:
    Title
    Change in monthly length for age Z-score (monthly LAZ)
    Description
    Change in length for age Z-score from 6 months to 18 months of age.
    Time Frame
    Measured on a monthly basis until 18 months of age
    Secondary Outcome Measure Information:
    Title
    Change in Serum Hemoglobin
    Description
    Change in serum hemoglobin from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in Serum retinol binding protein
    Description
    Change in serum retinol binding protein from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in serum transferrin receptors
    Description
    Change from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in serum ferritin
    Description
    Change from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in serum zinc
    Description
    Change from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in Weight for age Z-score
    Description
    This is the change in weight for age Z-score from 6 months to 18 months of age
    Time Frame
    Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
    Title
    Change in Weight for height Z-score
    Description
    This is the change in weight for length Z-score from 6 months to 18 months of age
    Time Frame
    Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
    Title
    Prevalence of diarrhea
    Description
    Prevalence of diarrhea over a 12 month period (duration of intervention)
    Time Frame
    Measured at baseline and then in a weekly surveillance for the duration of the intervention (12 months or 52 weeks)
    Title
    Prevalence of upper respiratory infections
    Description
    Prevalence of respiratory infections over a 12 month period (duration of the intervention)
    Time Frame
    Measured at baseline and then in a weekly surveillance for the duration of the intervention (12 months or 52 weeks)
    Title
    Change in serum C-reactive protein
    Description
    Change from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in serum alpha glycoprotein
    Description
    Change from baseline to endline (6 months to 18 months)
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)
    Title
    Change in Head Circumference for age
    Description
    This is the change in head circumference for age from 6 months to 18 months of
    Time Frame
    Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
    Title
    Change in MUAC (Mid Upper Arm Circumference)
    Description
    This is the change in MUAC for age from 6 months to 18 months of age
    Time Frame
    Measured at baseline and then on a monthly basis for the duration of the intervention (12 months)
    Title
    Change in Plasma Amino Acid levels
    Description
    This is the change in individual plasma amino acids from 6 months to 18 months
    Time Frame
    Baseline (6 months), Midline (12 months of age), Endline (18 months of age)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    6 Months
    Maximum Age & Unit of Time
    6 Months
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Non pre-term Singleton birth Exclusively or predominantly breast fed up to time of recruitment Parents planning to live in community for a period of 12 months and willing to participate in the trial for the entire period Receive informed consent from both parents and/or caregivers or from mother alone if single Exclusion Criteria: Severely anemic (<7 g/dl) (to be referred to Community Health Post (CHP) for routine care on anemia as recommended by Ghana Health Service) Severely malnourished (MUAC <110 mm) (to be referred to CHP with Community-based Management of Acute Malnutrition (CMAM) protocol) and/or use of CMAM protocol or below -2 standard deviations (SD) weight for age Z score
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Shibani Ghosh, PhD
    Organizational Affiliation
    Nevin Scrimshaw International Nutrition Foundation
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Gloria Otoo, PhD
    Organizational Affiliation
    University of Ghana
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Kwaku Tano-Debrah, PhD
    Organizational Affiliation
    University of Ghana
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    There is no plan to share individual participant data to other researchers
    Citations:
    PubMed Identifier
    19998866
    Citation
    de Pee S, Bloem MW. Current and potential role of specially formulated foods and food supplements for preventing malnutrition among 6- to 23-month-old children and for treating moderate malnutrition among 6- to 59-month-old children. Food Nutr Bull. 2009 Sep;30(3 Suppl):S434-63. doi: 10.1177/15648265090303S305.
    Results Reference
    background
    Citation
    Pan American Health Organization. Guiding Principles for Complementary Feeding of the Breast Fed Child p37, 2003
    Results Reference
    background
    Citation
    Ghana Statistical Service, Ghana Health Service, ICF Macro Ghana Demographic and Health Survey 2008, Accra, Ghana, p 512, 2009
    Results Reference
    background
    PubMed Identifier
    34660654
    Citation
    Furuta C, Sato W, Murakami H, Suri DJ, Otoo GE, Tano-Debrah K, Ghosh SA. Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial. Front Nutr. 2021 Sep 30;8:606002. doi: 10.3389/fnut.2021.606002. eCollection 2021.
    Results Reference
    derived

    Learn more about this trial

    Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants

    We'll reach out to this number within 24 hrs